Olink Proteomics INC
UEI LY8PXLZYEXL7 · MA · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$1.0M
- Department Of Agriculture$103K
- Department Of Defense$15K
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- N3239826P0101 ↗$15K
THIS REQUIREMENT IS FOR ONE PRE-PLAN INSPECTION AND A PREVENTATIVE MAINTENANCE VISIT, IF NEEDED.
- Ends
- Mar 11, 2027
- Started
- Mar 12, 2026
- Agency
- Department Of The Navy
- NAICS
- 541380
- 75N98026P00626 ↗$207K
PROJECT DESCRIPTION: THE PROJECT INVOLVES PERFORMING GENOME SEQUENCING OF DNA SAMPLES OBTAINED FROM PATIENTS DIAGNOSED WITH LEWY BODY DEMENTIA, AMYOTROPHIC LATERAL SCLEROSIS, ATYPICAL PARKINSONISM, OR FRONTOTEMPORAL DEMENTIA. THIS WILL BE DONE USING
- Ends
- May 27, 2027
- Started
- May 28, 2026
- Agency
- National Institutes Of Health
- NAICS
- 325414
- 75N98026P00909 ↗$35K
NHGRI: 1. OLINK REVEAL 2. OLINK DATA QC TRAINING & DATA REVIEW (EXPLORE-REVEAL) 3. SHIPPING AND HANDLING
- Ends
- Jun 30, 2027
- Started
- Jul 1, 2026
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75N98026P01085 ↗$47K
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
- Ends
- Jul 19, 2027
- Started
- Jul 20, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N98026P01119 ↗$47K
NCI: OLINK EXPLORE HT SERVICE. PRODUCT CODE 91959. REFERENCE QUOTE Q-35207-2.
- Ends
- Jul 28, 2027
- Started
- Jul 29, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541380
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| N3239826P0101 ↗ | THIS REQUIREMENT IS FOR ONE PRE-PLAN INSPECTION AND A PREVENTATIVE MAINTENANCE VISIT, IF NEEDED. | Department Of The Navy | 541380 | $15K | Mar 12, 2026 | Mar 11, 2027 |
| 75N98026P00626 ↗ | PROJECT DESCRIPTION: THE PROJECT INVOLVES PERFORMING GENOME SEQUENCING OF DNA SAMPLES OBTAINED FROM PATIENTS DIAGNOSED WITH LEWY BODY DEMENTIA, AMYOTROPHIC LATERAL SCLEROSIS, ATYPICAL PARKINSONISM, OR FRONTOTEMPORAL DEMENTIA. THIS WILL BE DONE USING | National Institutes Of Health | 325414 | $207K | May 28, 2026 | May 27, 2027 |
| 75N98026P00909 ↗ | NHGRI: 1. OLINK REVEAL 2. OLINK DATA QC TRAINING & DATA REVIEW (EXPLORE-REVEAL) 3. SHIPPING AND HANDLING | National Institutes Of Health | 334516 | $35K | Jul 1, 2026 | Jun 30, 2027 |
| 75N98026P01085 ↗ | MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH | National Institutes Of Health | 541380 | $47K | Jul 20, 2026 | Jul 19, 2027 |
| 75N98026P01119 ↗ | NCI: OLINK EXPLORE HT SERVICE. PRODUCT CODE 91959. REFERENCE QUOTE Q-35207-2. | National Institutes Of Health | 541380 | $47K | Jul 29, 2026 | Jul 28, 2027 |
Largest awards
- 75N95025P00454 ↗$250K
PCR BASED PROXIMITY EXTENSION ASSAY. PERIOD OF PERFORMANCE FROM 9/29/2025 - 9/28/2026. (AMBIS 2275381)
- Ends
- Sep 27, 2026
- Started
- Sep 28, 2025
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75N98026P00626 ↗$207K
PROJECT DESCRIPTION: THE PROJECT INVOLVES PERFORMING GENOME SEQUENCING OF DNA SAMPLES OBTAINED FROM PATIENTS DIAGNOSED WITH LEWY BODY DEMENTIA, AMYOTROPHIC LATERAL SCLEROSIS, ATYPICAL PARKINSONISM, OR FRONTOTEMPORAL DEMENTIA. THIS WILL BE DONE USING
- Ends
- May 27, 2027
- Started
- May 28, 2026
- Agency
- National Institutes Of Health
- NAICS
- 325414
- 75N95025P00403 ↗$139K
HUMAN OLINK PROTEOMICS ASSAY KIT. 30 DAYS ARO.
- Ends
- Sep 14, 2026
- Started
- Sep 15, 2025
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75F40125P00116 ↗$107K
PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES
- Ends
- Jul 30, 2026
- Started
- Jul 21, 2025
- Agency
- Food And Drug Administration
- NAICS
- 541720
- 1232SA26P0153 ↗$103K
REAGENTS COMPATIBLE WITH THE OLINK PROXIMITY EXTENSION ASSAY (PEA) TO CONDUCT ANALYSIS OF PROTEIN BIOMARKERS TO CONTINUE ONGOING STUDIES.
- Ends
- Jul 4, 2026
- Started
- May 5, 2026
- Agency
- Agricultural Research Service
- NAICS
- 334516
- 75N98026P01119 ↗$47K
NCI: OLINK EXPLORE HT SERVICE. PRODUCT CODE 91959. REFERENCE QUOTE Q-35207-2.
- Ends
- Jul 28, 2027
- Started
- Jul 29, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N98026P01085 ↗$47K
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
- Ends
- Jul 19, 2027
- Started
- Jul 20, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N90025P00555 ↗$45K
OLINK REAGENTS NEEDED BY THE CRITICAL CARE MEDICINE DEPARTMENT (CCMD) FOR RESEARCH.
- Ends
- Sep 29, 2025
- Started
- Jun 26, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325413
- 75N98026P00909 ↗$35K
NHGRI: 1. OLINK REVEAL 2. OLINK DATA QC TRAINING & DATA REVIEW (EXPLORE-REVEAL) 3. SHIPPING AND HANDLING
- Ends
- Jun 30, 2027
- Started
- Jul 1, 2026
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75N95D25P00057 ↗$25K
BIOLOGICAL AND REAGENT MATERIAL - OLINK EXPLORE HT REAGENT KIT
- Ends
- Sep 16, 2025
- Started
- Jul 17, 2025
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75N92025P00241 ↗$25K
[25-009960] THE LAB REQUIRES PROTEOMIC KITS IN ORDER TO ISOLATE AND QUANTIFY PROTEIN IN PLASMA AND BRONCHIOLE ALVEOLAR LAVAGE SAMPLES.
- Ends
- Dec 22, 2025
- Started
- Jun 23, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N98026P00887 ↗$25K
OLINK REAGENTS OLINK PROTEOMICS INC:1360742 [26-006363]
- Ends
- Sep 29, 2026
- Started
- Jun 30, 2026
- Agency
- National Institutes Of Health
- NAICS
- 334516
- 75N92025P00292 ↗$24K
[25-012663] THE LABORATORY FOR CHRONIC AIRWAY INFECTION REQUIRES PROTEOMICS ASSAYS FROM OLINK INC IN ORDER TO INVESTIGATE THE INK BETWEEN PLASMA MYOKINE ABUNDANCE AND PHYSICAL CAPACITY IN PATIENTS WITH NON-TUBERCULOUS MYCOBACTERIAL DISEASE
- Ends
- Sep 30, 2025
- Started
- Jul 31, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325414
- 75N92025P00037 ↗$20K
[25-003494] MARK JEAKLE REQUIRES ASSAY KITS FOR OLINK ASSAYS IN ORDER TO USE EQUIPMENT WE HAVE PURCHASED TO SAVE MONEY ON HAVING THE SAMPLES ASSAYED BY OLINK
- Ends
- Feb 15, 2025
- Started
- Dec 15, 2024
- Agency
- National Institutes Of Health
- NAICS
- 325414
- N3239826P0101 ↗$15K
THIS REQUIREMENT IS FOR ONE PRE-PLAN INSPECTION AND A PREVENTATIVE MAINTENANCE VISIT, IF NEEDED.
- Ends
- Mar 11, 2027
- Started
- Mar 12, 2026
- Agency
- Department Of The Navy
- NAICS
- 541380
- 75N90025P00138 ↗$15K
OLINK PROTEOMICS INC:1360742 [25-002530]
- Ends
- Apr 1, 2025
- Started
- Jan 2, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325414
- 75N90025P00491 ↗$11K
SERVICE AGREEMENT FOR THE OLINK SIGNATURE Q100 SYSTEM; OLINK PROTEOMICS INC:1360742 [25-007246] PERIOD OF PERFORMANCE 8/5/2025 - 8/4/2026
- Ends
- Aug 3, 2026
- Started
- Aug 4, 2025
- Agency
- National Institutes Of Health
- NAICS
- 811210
CARDIOTOXICITY BIOMARKER ANALYSIS FOR PLASMA SAMPLES FROM CANCER PATIENTS
- Ends
- Sep 28, 2025
- Started
- Sep 3, 2024
- Agency
- Food And Drug Administration
- NAICS
- 621511
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N95025P00454 ↗ | PCR BASED PROXIMITY EXTENSION ASSAY. PERIOD OF PERFORMANCE FROM 9/29/2025 - 9/28/2026. (AMBIS 2275381) | National Institutes Of Health | 334516 | $250K | Sep 28, 2025 | Sep 27, 2026 |
| 75N98026P00626 ↗ | PROJECT DESCRIPTION: THE PROJECT INVOLVES PERFORMING GENOME SEQUENCING OF DNA SAMPLES OBTAINED FROM PATIENTS DIAGNOSED WITH LEWY BODY DEMENTIA, AMYOTROPHIC LATERAL SCLEROSIS, ATYPICAL PARKINSONISM, OR FRONTOTEMPORAL DEMENTIA. THIS WILL BE DONE USING | National Institutes Of Health | 325414 | $207K | May 28, 2026 | May 27, 2027 |
| 75N95025P00403 ↗ | HUMAN OLINK PROTEOMICS ASSAY KIT. 30 DAYS ARO. | National Institutes Of Health | 334516 | $139K | Sep 15, 2025 | Sep 14, 2026 |
| 75F40125P00116 ↗ | PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES | Food And Drug Administration | 541720 | $107K | Jul 21, 2025 | Jul 30, 2026 |
| 1232SA26P0153 ↗ | REAGENTS COMPATIBLE WITH THE OLINK PROXIMITY EXTENSION ASSAY (PEA) TO CONDUCT ANALYSIS OF PROTEIN BIOMARKERS TO CONTINUE ONGOING STUDIES. | Agricultural Research Service | 334516 | $103K | May 5, 2026 | Jul 4, 2026 |
| 75N98026P01119 ↗ | NCI: OLINK EXPLORE HT SERVICE. PRODUCT CODE 91959. REFERENCE QUOTE Q-35207-2. | National Institutes Of Health | 541380 | $47K | Jul 29, 2026 | Jul 28, 2027 |
| 75N98026P01085 ↗ | MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH | National Institutes Of Health | 541380 | $47K | Jul 20, 2026 | Jul 19, 2027 |
| 75N90025P00555 ↗ | OLINK REAGENTS NEEDED BY THE CRITICAL CARE MEDICINE DEPARTMENT (CCMD) FOR RESEARCH. | National Institutes Of Health | 325413 | $45K | Jun 26, 2025 | Sep 29, 2025 |
| 75N98026P00909 ↗ | NHGRI: 1. OLINK REVEAL 2. OLINK DATA QC TRAINING & DATA REVIEW (EXPLORE-REVEAL) 3. SHIPPING AND HANDLING | National Institutes Of Health | 334516 | $35K | Jul 1, 2026 | Jun 30, 2027 |
| 75N95D25P00057 ↗ | BIOLOGICAL AND REAGENT MATERIAL - OLINK EXPLORE HT REAGENT KIT | National Institutes Of Health | 334516 | $25K | Jul 17, 2025 | Sep 16, 2025 |
| 75N92025P00241 ↗ | [25-009960] THE LAB REQUIRES PROTEOMIC KITS IN ORDER TO ISOLATE AND QUANTIFY PROTEIN IN PLASMA AND BRONCHIOLE ALVEOLAR LAVAGE SAMPLES. | National Institutes Of Health | 541380 | $25K | Jun 23, 2025 | Dec 22, 2025 |
| 75N98026P00887 ↗ | OLINK REAGENTS OLINK PROTEOMICS INC:1360742 [26-006363] | National Institutes Of Health | 334516 | $25K | Jun 30, 2026 | Sep 29, 2026 |
| 75N92025P00292 ↗ | [25-012663] THE LABORATORY FOR CHRONIC AIRWAY INFECTION REQUIRES PROTEOMICS ASSAYS FROM OLINK INC IN ORDER TO INVESTIGATE THE INK BETWEEN PLASMA MYOKINE ABUNDANCE AND PHYSICAL CAPACITY IN PATIENTS WITH NON-TUBERCULOUS MYCOBACTERIAL DISEASE | National Institutes Of Health | 325414 | $24K | Jul 31, 2025 | Sep 30, 2025 |
| 75N92025P00037 ↗ | [25-003494] MARK JEAKLE REQUIRES ASSAY KITS FOR OLINK ASSAYS IN ORDER TO USE EQUIPMENT WE HAVE PURCHASED TO SAVE MONEY ON HAVING THE SAMPLES ASSAYED BY OLINK | National Institutes Of Health | 325414 | $20K | Dec 15, 2024 | Feb 15, 2025 |
| N3239826P0101 ↗ | THIS REQUIREMENT IS FOR ONE PRE-PLAN INSPECTION AND A PREVENTATIVE MAINTENANCE VISIT, IF NEEDED. | Department Of The Navy | 541380 | $15K | Mar 12, 2026 | Mar 11, 2027 |
| 75N90025P00138 ↗ | OLINK PROTEOMICS INC:1360742 [25-002530] | National Institutes Of Health | 325414 | $15K | Jan 2, 2025 | Apr 1, 2025 |
| 75N90025P00491 ↗ | SERVICE AGREEMENT FOR THE OLINK SIGNATURE Q100 SYSTEM; OLINK PROTEOMICS INC:1360742 [25-007246] PERIOD OF PERFORMANCE 8/5/2025 - 8/4/2026 | National Institutes Of Health | 811210 | $11K | Aug 4, 2025 | Aug 3, 2026 |
| 75F40124P00440 ↗ | CARDIOTOXICITY BIOMARKER ANALYSIS FOR PLASMA SAMPLES FROM CANCER PATIENTS | Food And Drug Administration | 621511 | $0 | Sep 3, 2024 | Sep 28, 2025 |